Department of Gynecology, Guangdong Second Provincial General Hospital, Guangzhou, China.
Department of Intensive Care Unit, Puning People's Hospital, Puning, China.
Eur J Obstet Gynecol Reprod Biol. 2021 Jul;262:80-92. doi: 10.1016/j.ejogrb.2021.05.010. Epub 2021 May 10.
To explore the reproductive outcomes of women with a history of cesarean scar pregnancy (CSP) and the influence of various treatments on subsequent pregnancy outcomes.
The PubMed, Embase, Medline, Cochrane Library and ClinicalTrial.gov databases were searched for studies with the outcomes of pregnancy after CSP treatment. Studies that reported reproductive outcomes after CSP with more than 5 followed cases were included. The main data collected includes the treatment methods of CSP and subsequent pregnancy outcomes. The main information includes intrauterine pregnancy, recurrent CSP (RCSP), and spontaneous miscarriage, while the secondary information includes complications during pregnancies and the outcomes of childbirths. According to different treatments (conservative treatment, surgical treatment without resection of cesarean scar, and surgical treatment with resection of cesarean scar), a stratified analysis was carried out to compare the influence of treatments on subsequent pregnancy outcomes.
A total of 32 studies including 3380 cases of CSP met the inclusion criteria, of which 583 cases conceived again after treatment (including 292 cases of unexpected pregnancy), and finally 178 cases delivered successfully. The follow-up time ranged from 3 to 72 months. Among women with fertility requirements, a total of 291 cases in 403 women were successfully conceived during the follow-up period in 15 studies. Thence the pregnancy rate of women with fertility requirements was 76.2 %. Among all of the 583 successfully conceived women, 83.4 % of them had intrauterine pregnancy, while 15.3 % of cases were RCSP. The total ectopic pregnancy rate reached 16.6 %, covering RCSP and other sites of ectopic pregnancy. 14.6 % of intrauterine pregnancy experienced spontaneous miscarriage. The intrauterine pregnancy rates of the conservative treatment group, the surgical treatment without resection of cesarean scar group, and the surgical treatment with resection of cesarean scar group were 93.1 %, 80.1 % and 86.0 % respectively; the corresponding RCSP rates were 6.9 %, 15.6 % and 14.0 % respectively; and the corresponding spontaneous miscarriage rates were 20.7 %, 13.9 % and 22.2 % respectively.
The outcomes of reproduction after CSP included intrauterine pregnancy, RCSP and other sites of ectopic pregnancy. Women with a history of CSP still have a high pregnancy rate, but the risk of RCSP and spontaneous miscarriage is also increased. It is impossible to clarify the effect of different treatments on subsequent pregnancy. Whether the resection and repair of cesarean scar can ameliorate reproductive outcomes needs to be further assessed. Further large-scale prospective studies, even RCTs with long-term follow-up are needed to expound the outcomes of reproduction after CSP and the effect of different treatments on subsequent reproductive outcomes.
探讨剖宫产术后子宫瘢痕妊娠(CSP)患者的妊娠结局,以及不同治疗方法对后续妊娠结局的影响。
检索了 PubMed、Embase、Medline、Cochrane 图书馆和 ClinicalTrials.gov 数据库中关于 CSP 治疗后妊娠结局的研究。纳入了报告 CSP 后超过 5 例随访病例的生殖结局的研究。主要数据包括 CSP 的治疗方法和后续妊娠结局。主要信息包括宫内妊娠、复发性 CSP(RCSP)和自然流产,次要信息包括妊娠期间的并发症和分娩结局。根据不同的治疗方法(保守治疗、不切除剖宫产瘢痕的手术治疗和切除剖宫产瘢痕的手术治疗)进行分层分析,比较治疗方法对后续妊娠结局的影响。
共纳入 32 项研究,共 3380 例 CSP 患者,其中 583 例治疗后再次妊娠(包括 292 例意外妊娠),最终 178 例成功分娩。随访时间为 3 至 72 个月。在有生育要求的女性中,15 项研究中有 403 例女性中的 291 例在随访期间成功妊娠。因此,有生育要求的女性妊娠率为 76.2%。在所有 583 例成功妊娠的女性中,83.4%为宫内妊娠,15.3%为 RCSP。总的异位妊娠率达到 16.6%,包括 RCSP 和其他部位的异位妊娠。14.6%的宫内妊娠发生自然流产。保守治疗组、不切除剖宫产瘢痕的手术治疗组和切除剖宫产瘢痕的手术治疗组的宫内妊娠率分别为 93.1%、80.1%和 86.0%;相应的 RCSP 率分别为 6.9%、15.6%和 14.0%;自然流产率分别为 20.7%、13.9%和 22.2%。
CSP 后生殖结局包括宫内妊娠、RCSP 和其他部位的异位妊娠。有 CSP 病史的女性仍有较高的妊娠率,但 RCSP 和自然流产的风险也增加。目前尚无法明确不同治疗方法对后续妊娠的影响。切除和修复剖宫产瘢痕是否能改善生殖结局,还需要进一步评估。需要进一步开展大规模前瞻性研究,甚至是长期随访的 RCT,以阐述 CSP 后的生殖结局以及不同治疗方法对后续生殖结局的影响。